News/ News/ Oncology Cash round sets up trial of InteRNA’s microRNA for cancer Phil Taylor financing, gene silencing, immuno-oncology, InteRNA Technologies, microRNA, Oncology, solid tumour 0 Comment Dutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start Share X Cash round sets up trial of InteRNA’s microRNA for cancer https://pharmaphorum.com/news/cash-round-sets-up-trial-of-internas-microrna-for-cancer/